Douglass Winthrop Advisors, LLC Johnson & Johnson Transaction History

Douglass Winthrop Advisors, LLC

$4.77 Billion
Q2 2024

A detailed history of Douglass Winthrop Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Douglass Winthrop Advisors, LLC holds 102,443 shares of JNJ stock, worth $15.9 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

102,443

Previous 112,437 8.89%

Holding current value

$15.9 Million

Previous $17.8 Million 15.82%

% of portfolio

0.31%

Previous 0.38%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$144.38 - $157.78 $1.44 Million - $1.58 Million	-9,994 Reduced 8.89%	102,443 $15 Million
Q1 2024 May 13, 2024	SELL	$155.22 - $162.74 $287,157 - $301,069	-1,850 Reduced 1.62%	112,437 $17.8 Million
Q4 2023 Feb 12, 2024	SELL	$145.6 - $158.88 $282,464 - $308,227	-1,940 Reduced 1.67%	114,287 $17.9 Million
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $6,541 - $7,328	42 Added 0.04%	116,227 $18.1 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $221,029 - $237,869	-1,432 Reduced 1.22%	116,185 $19.2 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $1.14 Million - $1.36 Million	-7,545 Reduced 6.03%	117,617 $18.2 Million
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $143,379 - $160,912	895 Added 0.72%	125,162 $22.1 Million
Q3 2022 Nov 15, 2022	SELL	$161.33 - $179.52 $278,939 - $310,390	-1,729 Reduced 1.37%	124,267 $20.3 Million
Q2 2022 Aug 11, 2022	SELL	$168.19 - $186.01 $45,411 - $50,222	-270 Reduced 0.21%	125,996 $22.4 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $360,401 - $409,285	-2,279 Reduced 1.77%	126,266 $22.4 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $260,870 - $289,445	-1,673 Reduced 1.28%	128,545 $22 Million
Q3 2021 Nov 10, 2021	BUY	$161.5 - $179.47 $366,120 - $406,858	2,267 Added 1.77%	130,218 $21 Million
Q2 2021 Aug 02, 2021	SELL	$159.48 - $171.07 $503,956 - $540,581	-3,160 Reduced 2.41%	127,951 $21.1 Million
Q1 2021 May 13, 2021	SELL	$153.07 - $170.48 $182,918 - $203,723	-1,195 Reduced 0.9%	131,111 $21.5 Million
Q4 2020 Jan 27, 2021	BUY	$137.11 - $157.38 $140,674 - $161,471	1,026 Added 0.78%	132,306 $20.8 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $442,898 - $485,333	3,155 Added 2.46%	131,280 $19.5 Million
Q2 2020 Jul 17, 2020	BUY	$128.81 - $155.51 $513,951 - $620,484	3,990 Added 3.21%	128,125 $18 Million
Q1 2020 Apr 23, 2020	SELL	$111.14 - $153.99 $2.61 Million - $3.61 Million	-23,458 Reduced 15.89%	124,135 $16.3 Million
Q4 2019 Jan 10, 2020	SELL	$127.5 - $146.44 $431,077 - $495,113	-3,381 Reduced 2.24%	147,593 $21.5 Million
Q3 2019 Oct 08, 2019	SELL	$126.95 - $142.14 $1.19 Million - $1.33 Million	-9,375 Reduced 5.85%	150,974 $19.5 Million
Q2 2019 Jul 10, 2019	SELL	$131.15 - $144.24 $352,662 - $387,861	-2,689 Reduced 1.65%	160,349 $22.3 Million
Q1 2019 Apr 09, 2019	SELL	$125.72 - $139.79 $1.59 Million - $1.76 Million	-12,616 Reduced 7.18%	163,038 $22.8 Million
Q4 2018 Jan 16, 2019	BUY	$122.84 - $147.84 $240,643 - $289,618	1,959 Added 1.13%	175,654 $22.7 Million
Q3 2018 Oct 12, 2018	SELL	$121.58 - $142.88 $4.32 Million - $5.07 Million	-35,506 Reduced 16.97%	173,695 $24 Million
Q2 2018 Jul 24, 2018	SELL	$119.4 - $131.76 $248,471 - $274,192	-2,081 Reduced 0.98%	209,201 $25.4 Million
Q1 2018 May 08, 2018	BUY	$125.1 - $148.14 $1.49 Million - $1.77 Million	11,928 Added 5.98%	211,282 $27.1 Million
Q4 2017 Feb 13, 2018	BUY	$131.22 - $143.62 $207,065 - $226,632	1,578 Added 0.8%	199,354 $27.9 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $25.6 Million - $26.8 Million	197,776	197,776 $0

Others Institutions Holding JNJ

# of Institutions

4,239

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglass Winthrop Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglass Winthrop Advisors, LLC with notifications on news.

Account

Douglass Winthrop Advisors, LLC Johnson & Johnson Transaction History